Munafa Stock Market Course + Intraday & FNO calls 
Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Halozyme Therapeutics (HALO)
Technical Analysis Report for USA stock HALO Halozyme Therapeutics. Dated: 03 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock HALO Halozyme Therapeutics then click here. or read Experts views on Halozyme Therapeutics or Forecast & share price targets of Halozyme Therapeutics
Halozyme Therapeutics Opened at 66.00 and Closed at: 69.82, which is 5.07% of previous session's close. It moved within a range of 66.00 and 70.13
The session was a Bullish session with an average volume of 2144700, which is 18.82% of previous session's volumes.
- The stock has shown an up move, and its short term trend is also positive and in an uptrend.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
Support for tomorrow is 67.91 and resistance for tomorrow is 72.04
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 67.17, 64.52 resistance for tomorrow's hourly charts is 71.3, 72.78
10 Day SMA for Halozyme Therapeutics (HALO) is 68.22 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Halozyme Therapeutics (HALO) is 67.89 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Halozyme Therapeutics (HALO) is 66.44 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 68.93 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Halozyme Therapeutics is 69.34 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Halozyme Therapeutics is at 67.89 and 200 DMA is at 69.34, while 50 DMA and 100 DMA are at 66.44 and 68.93 respectively
Halozyme Therapeutics (HALO) moving average of 20 SMA is at 67.89 and 20 EMA is at 67.73
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Wed Jun | 69.82 | 67.89 | 67.73 |
| 02 Tue Jun | 66.28 | 67.71 | 67.51 |
| 01 Mon Jun | 68.14 | 67.69 | 67.64 |
| 29 Fri May | 66.54 | 67.52 | 67.59 |
| 28 Thu May | 68.18 | 67.39 | 67.7 |
| 27 Wed May | 68.66 | 67.16 | 67.65 |
Halozyme Therapeutics (HALO) moving average of 50 SMA is at 66.44 and 50 EMA is at 67.42
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Wed Jun | 69.82 | 66.44 | 67.42 |
| 02 Tue Jun | 66.28 | 66.28 | 67.32 |
| 01 Mon Jun | 68.14 | 66.22 | 67.36 |
| 29 Fri May | 66.54 | 66.12 | 67.33 |
| 28 Thu May | 68.18 | 66.06 | 67.36 |
| 27 Wed May | 68.66 | 65.99 | 67.33 |
Halozyme Therapeutics (HALO) moving average of 100 SMA is at 68.93 and 100 EMA is at 67.71
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Wed Jun | 69.82 | 68.93 | 67.71 |
| 02 Tue Jun | 66.28 | 68.96 | 67.67 |
| 01 Mon Jun | 68.14 | 69.05 | 67.7 |
| 29 Fri May | 66.54 | 69.1 | 67.69 |
| 28 Thu May | 68.18 | 69.14 | 67.71 |
| 27 Wed May | 68.66 | 69.16 | 67.7 |
Halozyme Therapeutics (HALO) moving average of 200 SMA is at 69.34 and 200 EMA is at 66.86
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Wed Jun | 69.82 | 69.34 | 66.86 |
| 02 Tue Jun | 66.28 | 69.34 | 66.83 |
| 01 Mon Jun | 68.14 | 69.34 | 66.84 |
| 29 Fri May | 66.54 | 69.33 | 66.83 |
| 28 Thu May | 68.18 | 69.32 | 66.83 |
| 27 Wed May | 68.66 | 69.3 | 66.82 |
Halozyme Therapeutics has performed better than U S in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Teleflex Incorporated in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Steris Plc in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Novartis Ag in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Iqvia Holdings in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Inspire Medical in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Bristol Myers in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Sutro Biopharma in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Sol Gel in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Omeros Corporation in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Intuitive Surgical in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Insmed Inc in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Immutep in short term. Holding Halozyme Therapeutics could be a better choice for now!
Icu Medical has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Icu Medical, about 3.91% more returns!
Halozyme Therapeutics has performed better than Ensign Group in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Cooper Companies in short term. Holding Halozyme Therapeutics could be a better choice for now!
Biolife Solutions has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Biolife Solutions, about 20.06% more returns!
Array Biopharma has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Array Biopharma, about 2.15% more returns!
Halozyme Therapeutics has performed better than Agios Pharmaceuticals in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics Technical analysis of indicators
Price action analysis of Halozyme Therapeutics (HALO) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Halozyme Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Halozyme Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 68.22 and Halozyme Therapeutics HALO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Halozyme Therapeutics HALO stock. Volume based technical analysis of Halozyme Therapeutics HALO stock is negative.
Halozyme Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock HALO Halozyme Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And HALO Experts View which covers a lot of information including buying and selling signals
HALO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Halozyme Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
